A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes
- 13 July 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 20 (8), 948-953
- https://doi.org/10.1038/nm.3619
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 DiabetesDiabetes, 2012
- Distinguishing Persistent Insulin Autoantibodies With Differential RiskDiabetes, 2011
- Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic rangeNature Communications, 2011
- Immune intervention in type 1 diabetesSeminars in Immunology, 2011
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialThe Lancet, 2011
- Approach to the Obese Adolescent with New-Onset DiabetesJournal of Clinical Endocrinology & Metabolism, 2010
- Epidemiology of Type 1 DiabetesEndocrinology and Metabolism Clinics of North America, 2010
- Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratoriesClinical Trials, 2010
- Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration studyThe Lancet, 2009
- Accepting clocks that tell time poorly: Fluid-phase versus standard ELISA autoantibody assaysClinical Immunology, 2007